Your browser doesn't support javascript.
loading
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.
Paz-Ares, Luis; Garassino, Marina Chiara; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Poltoratskiy, Artem; Trukhin, Dmytro; Hochmair, Maximilian J; Özgüroglu, Mustafa; Ji, Jun Ho; Statsenko, Galina; Conev, Nikolay; Bondarenko, Igor; Havel, Libor; Losonczy, György; Xie, Mingchao; Lai, Zhongwu; Godin-Heymann, Nadia; Mann, Helen; Jiang, Haiyi; Shrestha, Yashaswi; Goldman, Jonathan W.
Afiliación
  • Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Lung Cancer Unit CNIO-H120, Complutense University and Ciberonc, Madrid, Spain.
  • Garassino MC; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Chen Y; Department of Medicine, Section of Hematology/Oncology, Thoracic Oncology Unit, University of Chicago, Chicago, Illinois.
  • Reinmuth N; Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan.
  • Hotta K; Asklepios Lung Clinic, Member of the German Center for Lung Research (DZL), Munich-Gauting, Germany.
  • Poltoratskiy A; Okayama University Hospital, Okayama, Japan.
  • Trukhin D; Petrov Research Institute of Oncology, St. Petersburg, Russian Federation.
  • Hochmair MJ; Odessa Regional Oncological Dispensary, Odessa, Ukraine.
  • Özgüroglu M; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.
  • Ji JH; Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Statsenko G; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of South Korea.
  • Conev N; Omsk Regional Cancer Center, Omsk, Russian Federation.
  • Bondarenko I; Clinic of Medical Oncology, UMHAT St Marina, Varna, Bulgaria.
  • Havel L; Dnipropetrovsk Medical Academy, Dnipro, Ukraine.
  • Losonczy G; Thomayer Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Xie M; Semmelweis University, Budapest, Hungary.
  • Lai Z; AstraZeneca, Waltham, Massachusetts.
  • Godin-Heymann N; AstraZeneca, Gaithersburg, Maryland.
  • Mann H; AstraZeneca, Cambridge, United Kingdom.
  • Jiang H; AstraZeneca, Cambridge, United Kingdom.
  • Shrestha Y; AstraZeneca, Gaithersburg, Maryland.
  • Goldman JW; AstraZeneca, Gaithersburg, Maryland.
Clin Cancer Res ; 30(4): 824-835, 2024 02 16.
Article en En | MEDLINE | ID: mdl-37801329
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Pulmonar de Células Pequeñas / Anticuerpos Monoclonales Humanizados / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Pulmonar de Células Pequeñas / Anticuerpos Monoclonales Humanizados / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: España